Latest news with #MikeMatson
Yahoo
16-07-2025
- Business
- Yahoo
Zimmer bets on autonomous surgery with Monogram purchase
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Zimmer Biomet hopes to round out its surgical robotics portfolio with its planned $177 million purchase of Monogram Technologies, which was announced Monday. The acquisition could offer more customer choice, analysts wrote, but they also questioned whether surgeons will prefer an autonomous robot. Monogram received Food and Drug Administration clearance in March for a semi-autonomous, AI-navigated robot called mBôs, to be used in total knee replacement surgeries. The company plans to launch mBôs with Zimmer's Persona knee implants in early 2027, according to an investor presentation. Monogram is working on a fully autonomous version of the robot, which would be hands-free and activated using foot pedals, that it plans to launch in late 2027 or early 2028. Zimmer already has a robot that can be used for total knee replacements, called Rosa, but that system currently does not work with CT imaging and uses manual cutting. After closing, Zimmer expects to have 'the most comprehensive suite of customer-centric technology solutions, ranging from simplified navigation, such as OrthoGrid, to non-CT based robotics with Rosa, and fully autonomous robots with mBôs,' according to the investor presentation. Analysts said the deal is designed to give surgeons more options, but also raised questions about the acquisition. Mike Matson, an analyst with Needham, said buying Monogram may 'improve and differentiate' Zimmer's robotics, but questioned the level of surgeon interest in a fully automated robotics system, in a research note published Monday. BTIG analyst Ryan Zimmerman wrote in a research note that the price was high for a robotics system that has not sold any units yet, and asked what the deal means for Rosa, given the updates planned for the coming quarters. 'This is about customer choice, defining the fully autonomous category of robotics, and appealing to surgeons who prefer autonomous cutting over manual cutting (which is ROSA today),' Zimmerman wrote, citing a conversation with the orthopedic firm's management. Shagun Singh, an analyst with RBC Capital Markets, wrote that Zimmer plans to grow its business by gaining more share in the robotic market, increasing how many procedures are done using robotics, driving more revenue per procedure, and expanding the market by creating a new category of fully autonomous robots. More acquisitions likely to come Zimmer also used the announcement to outline future plans for its robotics program. The company's Rosa robots are 'rapidly approaching 2,000 installations worldwide' and are a market leader outside of the U.S., Zimmer said in a press release. Zimmer received FDA clearance last year to use Rosa for robot-assisted shoulder replacements, and plans a full launch of the feature in early 2026. The company is working on a posterior hip feature for Rosa for the second half of 2026, and a CT imaging feature for early 2027, according to the investor presentation. Last year, Zimmer bought OrthoGrid Systems, which makes AI guidance systems for total hip replacement surgeries. It also struck a distribution agreement with Think Surgical, which makes a CT-enabled, handheld robot. 'Management explained that these technologies are not competitive, but allow a more complimentary suite,' Singh wrote. In April, Zimmer bought Paragon 28, an orthopedics company focused on foot and ankle procedures, for $1.1 billion. Analysts see Zimmer as poised to continue its streak of acquisitions. Needham's Matson wrote that 'despite the recent acquisition of Paragon 28 and today's announcement, we still think that [Zimmer] may pursue additional acquisitions in higher-growth orthopedic subcategories like data/AI, enabling technologies, sports medicine, and extremities.' Recommended Reading Zimmer to buy robotics firm Monogram for about $177M Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
06-06-2025
- Politics
- Yahoo
Mayor Matson gives final State of the City Address
Davenport mayor Mike Matson delivered his final State of the City Address Thursday afternoon. He has announced that he is not seeking re-election, but for now his message to the city of Davenport is continual improvement. 'I can't thank the conversations I've had, uncomfortable or comfortable, but I need to thank you for that,' Matson said. 'I give credit to) the folks that do the work and work together in different entities to give city council goals and ideas on what to do. It's because of you.' The mayor pointed out improvements across Davenport, including a 66 percent decrease in shots fired over the last five years. 'Davenport, again, just like the parks', Good Neighbor Project, recognized as an example of how to do gun violence intervention, how to do gun and crime reduction, 'Matson said. He also noted that nearly a billion dollars have been investment in the northern part of the city. 'Set the table so businesses, when they are interested in coming, are ready to go,' Matson said. 'That's what the city council, the staff, that's what a lot of people have told us to do, and we are doing it.' Matson added that the key to continuing a positive trajectory is collaboration. 'There are no words to say how important it is for everyone in this room, much less everybody out in whatever world you are, to work together,' Matson said. 'Come to the same vision of how do we improve whatever it is we want to improve.' Matson said that Davenport's future is bright. 'We are doing a good thing. Maybe we can improve here, but thank God we have partners, thank God we have people who care about the community, and thank God we have people to work together,' Matson said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
02-06-2025
- Business
- Yahoo
Boston Scientific ends TAVR sales; J&J shares Monarch robot data
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific said Wednesday it plans to end worldwide sales of its transcatheter aortic valve replacement systems, citing regulatory hurdles. The company will discontinue its Acurate Neo2 and Acurate Prime TAVR systems, which are sold in Europe, and will not pursue Food and Drug Administration approval for the devices. Boston Scientific said in a regulatory filing that the decision followed recent discussions with regulators, adding that the products faced increased requirements to maintain approvals in global markets and to obtain approvals in new regions. The company had told investors the 'path to approval in the U.S. was unclear and the approval requirements in Europe would be even greater,' Needham analyst Mike Matson wrote in a research note Wednesday. The decision followed Boston Scientific missing its primary endpoint in a trial comparing its Acurate Neo2 device to other TAVR systems. The Acurate business brought in about $200 million in sales last year, Matson wrote. 'Given the product's mixed clinical track record and complicated path to US approval, we're not surprised by Boston's choice to discontinue the product and redirect its time, effort, and dollars elsewhere,' J.P. Morgan analyst Robbie Marcus wrote in a research note. Marcus views the decision as the right strategy for Boston Scientific, even if the company takes a hit in the short term. Johnson & Johnson shared results of a study that found the company's Monarch bronchoscopy robot was able to reach small, peripheral lung nodules in more than 98% of cases. The robotic platform was able to locate and biopsy the nodules with a safety rate comparable to non-robotic bronchoscopy techniques, the company said in a Wednesday announcement. The TARGET study was published in Chest Journal on April 26 and was sponsored by J&J subsidiary Auris Health. The single-arm trial enrolled 679 people in the U.S., Canada and Hong Kong. Auris first received FDA clearance for the Monarch robot in 2018. J&J acquired the company a year later for $3.4 billion in cash. A software update for the system, intended to improve accuracy in reaching suspicious nodules, was cleared in March. Medtronic said Tuesday that a technology it is developing for its pulse oximeters was accepted into the FDA's Safer Technologies Program. The program is intended to support expedited development, assessment and review of devices that are expected to improve the safety of currently available devices. Medtronic is developing a technology to integrate patient- and sensor-specific data into oxygen saturation calculations used by its Nellcor pulse oximeters. Pulse oximeters have faced recent scrutiny by the FDA after studies have shown the devices may be less accurate for people with darker skin pigmentation. The agency issued a draft guidance in January updating testing recommendations for the devices, but it has not yet finalized the guidance. Last year, Medtronic agreed to provide labels and brochures to California hospital customers about the potential for flawed readings as part of a settlement with Roots Community Health, which sued 13 companies that make or sell pulse oximeters over the risk of disparities in treatment. Recommended Reading Edwards gains expanded TAVR label for asymptomatic patients Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20-05-2025
- Business
- Yahoo
New Amazon facility coming to Davenport
Amazon is expanding in Davenport with a new facility. Growing customer demand led to a second facility in Davenport, a 114,000 square-foot last-mile delivery station near the current Amazon Robotics Fulfillment Center at 2022 Research Parkway. This type of facility typically creates over 100 direct and indirect job opportunities, including driving opportunities through the Delivery Service Partner (DSP) and Amazon Flex programs as the company serves thousands of customers in Scott County and beyond. Construction just started on the facility, which is expected to be completed in late 2025. Employees in Amazon's U.S. customer fulfillment and transportation earn an average of over $22 per hour.'The City is happy to see Amazon grow its footprint in Davenport's Eastern Iowa Industrial Center,' said Davenport Mayor Mike Matson. 'We're grateful Amazon chose to do business here, and we're proud of the Davenport community for supporting this expansion.' This new last-mile facility will be the final stage of Amazon's fulfillment process and ensure fast, everyday delivery to customers' doorsteps. The facility will bring even faster delivery for customers throughout the region, including neighboring rural communities. 'Opening our second Davenport site in three years and our sixth in the past two years across Iowa is a testament to expanding the great communities we serve and the new jobs we're bringing across the region,' said Jason Vangalis, Amazon economic development manager. 'Davenport's strategic Midwest location with direct access to major highways and talented workforce also played a key role in this area's expansion.' 'We are thrilled that Amazon has chosen to expand at their current campus in Davenport,' said Peter Tokar III, Quad Cities President & CEO. 'The expansion will bring new jobs as Amazon continues to serve the Quad Cities area and beyond.' Amazon's Robotics Fulfillment Center, also in Davenport, opened in October 2023 and employs about 2,000 people. The facility features the latest generation of Amazon robotics, including over 5,000 robots helping move products through the 2.3 million-square-foot building while fulfilling about 130,000 customer orders daily. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
14-05-2025
- Business
- Yahoo
QC leaders react to Dept. of Defense memo that would impact Arsenal staffing, local economy
The Rock Island Arsenal Defense Alliance's message Tuesday morning was simple: Protect Rock Island Arsenal. Protect our economy. Protect our national security. 'This is all about unity for the Rock Island Arsenal, and unity for the Rock,' said Mike Matson, Davenport mayor and chair of the Rock Island Arsenal Defense Alliance. 'What's happening here could be a huge impact to the island and to the community,' said Trish Huber, vice chair of the Rock Island Arsenal Defense Alliance. 'The influence and output the Arsenal has to both our region and the nation cannot be understated,' said Peter Tokar III, president and CEO of the Quad Cities Chamber. It's in response to a Department of Defense memo that would merge the Army Sustainment Command (ASC) and Joint Munitions Command (JMC). Both are headquartered on the Arsenal. The merger, though, could eliminate up to 400 jobs.'Such a move risks sacrificing effectiveness for perceived efficiency,' Matson said.'When I look at the Second Army's current transformation initiatives, they are significant, and they will be disruptive,' Huber said. 'It will be a challenge to implement those initiatives and not disrupt the critical missions that are performed across (the Department of Defense), especially focused on the island.' The JMC covers ammunition for all U.S. services, while the ASC delivers fuel, food and shelter to vehicles and parts worldwide.'This action is being driven by a desire we believe to cut overhead and consolidate logistics functions,' Matson said. 'The collective impact of the work that goes on at the Arsenal amounts to billions of dollars in regional economic impact to the Quad Cities and beyond,' Tokar III said. Quad Cities leaders are asking residents to show their support for the Arsenal. 'We're asking all Quad Citians to join together by signing a petition, urging our federal leaders to protect this asset that is the rock island arsenal,' Matson said. To view the petition, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
